Y-Mabs Therapeutics Overview
Y-Mabs Therapeutics Target Price
Analysts' 12-month price predictions for YMAB.
Share Price
$4.71
Average Target Price
$7.00
48.6% upside
48.6% upside1 analysts in the last 4 months
High: $7 | Low: $7
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-03-05 | Morgan Stanley | $7 | 48.6% upside |  |
| 2024-11-11 | BMO CapitalEtzer Darout | $24 | 409.6% upside | |
| 2024-06-28 | Truist FinancialNicole Germino | $21 | 345.9% upside | |
| 2024-05-10 | H.C. WainwrightRobert Burns | $22 | 367.1% upside | |
| 2024-04-05 | BMO CapitalEtzer Darout | $26 | 452% upside | |
| 2023-05-10 | WedbushYMAB)to Outperform | $13 | 176% upside | |